Anna-Maria Hoffmann-Vold, MD, PhD

Oslo University Hospital
Oslo, Norway

Anna-Maria Hoffmann-Vold is the Head of the inflammatory and fibrotic rheumatic disease research area and the systemic sclerosis (SSc) outpatient clinic at the Oslo University Hospital. She is a convenor for the ERS/EULAR guideline development for connective tissue diseases (CTD) associated ILD (CTD-ILD) and a member of the EULAR Quality of Care Committee.
Dr Hoffmann-Vold’s main expertise and interest is on clinical and translational research related to SSc and other connective tissue diseases (CTDs) with an emphasis on interstitial lung disease, pulmonary arterial hypertension, development of management recommendations, conduction of clinical trials and the potential role of gut microbiota.

Disclosure information not submitted.

Presentation(s):

• 0522: Cohort Enrichment Strategies for Progressive Interstitial Lung Disease in Systemic Sclerosis from EUSTAR

  Saturday, November 12, 2022
  4:00 PM – 4:10 PM Eastern Time

• 1536: Progressive Interstitial Lung Disease Is Frequent Also in Late Disease Stages in Systemic Sclerosis Patients from EUSTAR

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time

• 14M116: Abstracts: Systemic Sclerosis and Related Disorders – Clinical II: Clinical Phenotypes (1657–1662)

  Monday, November 14, 2022
  9:00 AM – 10:30 AM Eastern Time

• 2049: ILD Associated with Primary Sjögren’s Syndrome Is Frequently Progressive

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time